A Trial Platform of Enhanced care for Depression in Primary Care

ISRCTN ISRCTN63222059
DOI https://doi.org/10.1186/ISRCTN63222059
Secondary identifying numbers G0300677
Submission date
17/05/2004
Registration date
14/07/2004
Last edited
02/07/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof David Richards
Scientific

Dept Health Sciences
Seebohm Rowntree Building
University of York
University Road
Heslington
York
YO10 5DD
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeNot Specified
Scientific title
Study objectives1. To design and refine a standardised ECD intervention protocol appropriate to the UK primary health care setting and acceptable to clinicians, practitioners and patients
2. To estimate contamination, clustering and effect size of the intervention within a pilot Phase II trial
3. To estimate trial recruitment rates through monitoring recruitment rates within the pilot Phase II trial
4. To examine the issue of treatment integrity and acceptability by monitoring the implementation of the ECD intervention protocol within a pilot Phase II trial and conducting qualitative stakeholder interviews
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMental and Behavioural Disorders
Intervention1. Enhanced care for depression
2. Usual care
Intervention typeOther
Primary outcome measureClinical response (change from baseline Hamilton depression HAM-D score), 50% reduction in depressive symptoms
Secondary outcome measures1. Quality of life (SF-12 & EQ-5D)
2. Health care utilisation (including GP visits, medication use, secondary care referrals)
3. Prescribing and adherence to medication measured against NICE guidelines (from individual patient records, filled prescriptions and patient self report)
Overall study start date01/07/2004
Completion date30/03/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants144
Key inclusion criteriaDepression presenting in Primary Care
Key exclusion criteriaDepression not as primary diagnosis; suicidal intent
Date of first enrolment01/07/2004
Date of final enrolment30/03/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Dept Health Sciences
York
YO10 5DD
United Kingdom

Sponsor information

University of York (UK)
University/education

Prof Trevor Sheldon
Department of Health Sciences
Seebohhm Rowntree Building
University of York
University Road
Heslington
York
YO10 5DD
England
United Kingdom

Website http://www.york.ac.uk/
ROR logo "ROR" https://ror.org/04m01e293

Funders

Funder type

Research council

Medical Research Council (MRC) (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2006 Yes No
Results article results 01/07/2009 Yes No